The store will not work correctly when cookies are disabled.
(R)3-(1-Cyclopropyl-ethyl)-7-(2,4-dichloro-phenyl)-2-ethyl-3H-imidazo[4,5-b]pyridine
ID: ALA3085294
PubChem CID: 76313469
Max Phase: Preclinical
Molecular Formula: C19H19Cl2N3
Molecular Weight: 360.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1nc2c(-c3ccc(Cl)cc3Cl)ccnc2n1[C@H](C)C1CC1
Standard InChI: InChI=1S/C19H19Cl2N3/c1-3-17-23-18-15(14-7-6-13(20)10-16(14)21)8-9-22-19(18)24(17)11(2)12-4-5-12/h6-12H,3-5H2,1-2H3/t11-/m1/s1
Standard InChI Key: AAARPHXZKXDSID-LLVKDONJSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
5.7285 0.6722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9394 0.4091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7285 -0.6681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9394 -0.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2171 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2254 -0.8309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2254 -1.6576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9415 1.4738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3528 2.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9394 -2.0710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2254 0.8225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1273 2.8434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5511 2.2547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9394 -2.8935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5115 -2.0710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2254 -3.3110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6534 -1.6576 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.0438 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5115 -2.8977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5115 0.4091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5115 -0.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2254 -4.1378 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.7306 1.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4571 -0.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 5 2 0
4 2 1 0
5 1 1 0
6 4 2 0
7 6 1 0
8 1 1 0
8 9 1 1
10 7 1 0
11 2 2 0
12 9 1 0
13 9 1 0
14 10 2 0
15 7 2 0
16 19 2 0
17 10 1 0
18 5 1 0
19 15 1 0
20 11 1 0
21 20 2 0
22 16 1 0
23 8 1 0
24 18 1 0
4 3 1 0
13 12 1 0
6 21 1 0
14 16 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.29 | Molecular Weight (Monoisotopic): 359.0956 | AlogP: 5.94 | #Rotatable Bonds: 4 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 2.46 | CX LogP: 5.51 | CX LogD: 5.51 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -1.19 |
References
1. Arvanitis AG, Rescinito JT, Arnold CR, Wilde RG, Cain GA, Sun JH, Yan JS, Teleha CA, Fitzgerald LW, McElroy J, Zaczek R, Hartig PR, Grossman S, Arneric SP, Gilligan PJ, Olson RE, Robertson DW.. (2003) Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands., 13 (1): [PMID:12467631] [10.1016/s0960-894x(02)00833-8] |